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Pulmonary drug delivery represents a new alternative treatment way for both local and 
systemic diseases (where, in addition to its beneficial properties, one-tenth of the active 
ingredient is sufficient to achieve the required effect by oral administration [1]). To accomplish 
this, the international literature distinguishes between nebulizers, pressurized metered-dose 
inhalers, and dry powder inhalers (DPIs). The development of the latter can be considered a 
"hot topic" these days, due to a large number of formulation options available. A number of 
solid excipients are being tested for their effect on aerosolization [2], but not a lot of data are 
currently available on the aerosolization effect of organic solvents (OSs) used in DPI sample 
preparation [3]. Thus, the purpose of the present work was to investigate the effects of a given 
OS in different concentrations on powder properties and in vitro lung model results of DPI 
formulations, and to develop the microcomposites for pharmaceutical form prepared in the 
ideal percentage of OS using different DPI capsule types in stability test. The study showed 
that the percentage of the OS of our choice during spray drying production influences the 
physical properties of the samples and thus the aerosolization. As a result of the formulations 
development for pharmaceutical form made in the optimal percentage of the applied OS, 
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